Immunostaining revealed that BRG1 (SMARCA4) expression was lost in the tumor cells, whereas INI1 (SMARCB1) and BRM (SMARCA2) proteins were retained (Figure 1C). The gene discussed is SMARCA4; the disease is neoplasm.